Abstract
Dual mitochondria targeting fluorescent F16-TPP analogues were designed and synthesized. Uptake and cytotoxicity studies indicate that FF16 and FF16-TPP, two compounds discovered in this study, are promising mitochondria targeting theranostic agents.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
-
Antineoplastic Agents* / chemical synthesis
-
Antineoplastic Agents* / pharmacology
-
Antineoplastic Agents* / therapeutic use
-
Cell Line, Tumor
-
Cell Proliferation / drug effects
-
Drug Design
-
Humans
-
Indoles* / chemical synthesis
-
Indoles* / pharmacology
-
Indoles* / therapeutic use
-
Mitochondria / metabolism*
-
Onium Compounds* / chemical synthesis
-
Onium Compounds* / pharmacology
-
Onium Compounds* / therapeutic use
-
Optical Imaging
-
Organophosphorus Compounds* / chemical synthesis
-
Organophosphorus Compounds* / pharmacology
-
Organophosphorus Compounds* / therapeutic use
-
Pyridinium Compounds* / chemical synthesis
-
Pyridinium Compounds* / pharmacology
-
Pyridinium Compounds* / therapeutic use
Substances
-
Antineoplastic Agents
-
Indoles
-
Onium Compounds
-
Organophosphorus Compounds
-
Pyridinium Compounds
-
4-(2-(indol-3-yl)vinyl)-1-methylpyridinium
-
tetraphenylphosphonium